Mitsuyoshi Namba

Summary

Affiliation: Hyogo College of Medicine
Country: Japan

Publications

  1. doi request reprint New strategy for the treatment of type 2 diabetes mellitus with incretin-based therapy
    Mitsuyoshi Namba
    Division of Diabetes and Metabolism, Department of Internal Medicine, Hyogo College of Medicine, 1 1 Mukogawa cho, Nishinomiya, Hyogo 663 8501, Japan
    Clin Exp Nephrol 17:10-5. 2013
  2. pmc Incretin responses to oral glucose load in Japanese non-obese healthy subjects
    Etsuko Nagai
    Division of Diabetes and Metabolism, Department of Internal Medicine, Hyogo College of Medicine, 1 1, Mukogawa cho, Nishinomiya, Hyogo, 663 8501, Japan
    Diabetes Ther 2:20-8. 2011
  3. ncbi request reprint Effect of additional administration of acarbose on blood glucose fluctuations and postprandial hyperglycemia in patients with type 2 diabetes mellitus under treatment with alogliptin
    Yoshiki Kusunoki
    Division of Diabetes and Metabolism, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya 663 8501, Japan
    Endocr J 60:431-9. 2013
  4. ncbi request reprint Effects of miglitol in combination with intensive insulin therapy on blood glucose control with special reference to incretin responses in type 1 diabetes mellitus
    Etsuko Nagai
    Division of Diabetes and Metabolism, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Japan
    Endocr J 58:869-77. 2011
  5. doi request reprint Effects of gliclazide on platelet aggregation and the plasminogen activator inhibitor type 1 level in patients with type 2 diabetes mellitus
    Hiroyuki Konya
    Division of Diabetes and Metabolism, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Hyogo 663 8501, Japan
    Metabolism 59:1294-9. 2010
  6. ncbi request reprint Add-on therapy with the DPP-4 inhibitor sitagliptin improves glycemic control in insulin-treated Japanese patients with type 2 diabetes mellitus
    Tomoyuki Katsuno
    Division of Diabetes and Metabolism, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya 663 8501, Japan
    Endocr J 60:733-42. 2013
  7. ncbi request reprint [Incretin-based therapy in patients with type 1 diabetes mellitus]
    Jun ichiro Miyagawa
    Division of Diabetes and Metabolism, Internal Medicine, Hyogo College of Medicine
    Nihon Rinsho 69:923-9. 2011

Collaborators

  • Etsuko Nagai
  • Jun ichiro Miyagawa
  • Tomoyuki Katsuno
  • Masayuki Miuchi
  • Yoshiki Kusunoki
  • Tomoya Hamaguchi
  • Hiroyuki Konya
  • Hiroki Ikeda
  • Fumihiro Ochi
  • Kazuki Murai
  • Makiko Myojin
  • Takashi Ikawa
  • Toshihiro Matsuo
  • Kenichi Ida
  • Masaru Tokuda
  • Kana Miyakoshi
  • Eizo Kakishita
  • Tetsuya Ishikawa
  • Yoshikazu Hasegawa
  • Kousuke Kohri
  • Akiko Umehara
  • Akira Suehiro
  • Kahori Satani

Detail Information

Publications7

  1. doi request reprint New strategy for the treatment of type 2 diabetes mellitus with incretin-based therapy
    Mitsuyoshi Namba
    Division of Diabetes and Metabolism, Department of Internal Medicine, Hyogo College of Medicine, 1 1 Mukogawa cho, Nishinomiya, Hyogo 663 8501, Japan
    Clin Exp Nephrol 17:10-5. 2013
    ..Indications and/or contraindications for incretin-based therapy should be clarified by prospectively studying the experiences of Japanese T2DM patients undergoing this therapy in the clinical setting...
  2. pmc Incretin responses to oral glucose load in Japanese non-obese healthy subjects
    Etsuko Nagai
    Division of Diabetes and Metabolism, Department of Internal Medicine, Hyogo College of Medicine, 1 1, Mukogawa cho, Nishinomiya, Hyogo, 663 8501, Japan
    Diabetes Ther 2:20-8. 2011
    ....
  3. ncbi request reprint Effect of additional administration of acarbose on blood glucose fluctuations and postprandial hyperglycemia in patients with type 2 diabetes mellitus under treatment with alogliptin
    Yoshiki Kusunoki
    Division of Diabetes and Metabolism, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya 663 8501, Japan
    Endocr J 60:431-9. 2013
    ..The beneficial effects may also protect the endocrine pancreas and inhibit body weight gain...
  4. ncbi request reprint Effects of miglitol in combination with intensive insulin therapy on blood glucose control with special reference to incretin responses in type 1 diabetes mellitus
    Etsuko Nagai
    Division of Diabetes and Metabolism, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Japan
    Endocr J 58:869-77. 2011
    ..MTT findings suggest that this combination therapy improves blood glucose control by delaying carbohydrate absorption and modifying the responses of incretins, GIP, and GLP-1...
  5. doi request reprint Effects of gliclazide on platelet aggregation and the plasminogen activator inhibitor type 1 level in patients with type 2 diabetes mellitus
    Hiroyuki Konya
    Division of Diabetes and Metabolism, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Hyogo 663 8501, Japan
    Metabolism 59:1294-9. 2010
    ..Taken together, the results show that gliclazide may be more useful for the prevention of diabetic vascular complications than glibenclamide...
  6. ncbi request reprint Add-on therapy with the DPP-4 inhibitor sitagliptin improves glycemic control in insulin-treated Japanese patients with type 2 diabetes mellitus
    Tomoyuki Katsuno
    Division of Diabetes and Metabolism, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya 663 8501, Japan
    Endocr J 60:733-42. 2013
    ..The results of this investigation confirmed that add-on therapy with sitagliptin to various insulin regimens could improve glycemic control without severe hypoglycemia and/or weight gain...
  7. ncbi request reprint [Incretin-based therapy in patients with type 1 diabetes mellitus]
    Jun ichiro Miyagawa
    Division of Diabetes and Metabolism, Internal Medicine, Hyogo College of Medicine
    Nihon Rinsho 69:923-9. 2011
    ..Taken together, incretin-based therapy may be worth testing in patients with type 1 diabetes...